The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome

İbrahim Etem Çelik1, Selçuk Öztürk2, Mikail Yarlıoğlu1

  • 1Department of Cardiology, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Türkiye.

PubMed

Insights

The atherogenic index of plasma (AIP) did not predict no-reflow phenomenon (NRP) in acute coronary syndrome (ACS) patients. Peak troponin T levels, however, independently predicted NRP in this patient group.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • The atherogenic index of plasma (AIP) is a key indicator of plasma atherogenicity, with elevated levels associated with increased cardiac event risk.
  • The no-reflow phenomenon (NRP) is a critical complication following percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients.
  • Understanding predictors of NRP is crucial for improving patient outcomes after PCI.

Purpose of the Study:

  • To investigate the association between admission atherogenic index of plasma (AIP) and the occurrence of no-reflow phenomenon (NRP) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • A retrospective analysis was conducted on 884 ACS patients, categorized into NRP (-) (n=662) and NRP (+) (n=186) groups.
  • Atherogenic index of plasma (AIP) was calculated using the formula: log10 (triglyceride/high-density lipoprotein cholesterol ratio).
  • Statistical analyses included receiver operating characteristic (ROC) curve analysis and logistic regression to assess the prognostic value of AIP and peak troponin T for NRP.

Main Results:

  • Patients with NRP exhibited higher admission AIP levels compared to those without NRP.
  • Univariate analysis showed AIP was associated with NRP (OR: 2.46, P=.001), but this association did not hold in multivariate analysis (OR: 2.11, P=.422).
  • Peak troponin T (log10) emerged as an independent prognostic factor for NRP (OR: 0.13, P<.001).

Conclusions:

  • Admission atherogenic index of plasma (AIP) is not a statistically significant predictor of no-reflow phenomenon (NRP) in ACS patients treated with PCI.
  • Peak troponin T (log10) is identified as an independent prognostic parameter for NRP in this population.
  • These findings highlight the importance of troponin T levels in predicting adverse outcomes post-PCI in ACS patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
7
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11